Belite Bio, Inc Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Belite Bio, Inc (BLTE) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $117.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-31
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|
| 2025-12-31 | $117.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | -$269.00K 20-F · filed 2026-03-31 |
| 2023-12-31 | $9.00K 20-F · filed 2026-03-31 |
| 2022-12-31 | -$366.00K 20-F · filed 2025-03-17 |
| 2021-12-31 | -$161.00K 20-F · filed 2024-03-12 |
| 2020-12-31 | $4.00K 20-F · filed 2023-03-31 |